| Filed | Form | Description | |
|---|---|---|---|
| 12/19/25 | DEFA14A | DEFA14A | → |
| 12/9/25 | DEFA14A | DEFA14A | → |
| 12/3/25 | DEFM14A | DEFM14A | → |
| 11/19/25 | DEFA14A | DEFA14A | → |
| 11/19/25 | DEFA14A | DEFA14A | → |
| 11/17/25 | DEFA14A | DEFA14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 2/18/26 | 4 | PRIMARY DOCUMENT | → |
| 2/18/26 | 3 | PRIMARY DOCUMENT | → |
| 2/12/26 | 4 | OWNERSHIP DOCUMENT | → |
| 2/12/26 | 4 | OWNERSHIP DOCUMENT | → |
| 2/12/26 | 4 | OWNERSHIP DOCUMENT | → |
| 2/12/26 | 4 | OWNERSHIP DOCUMENT | → |
| ↓ | |||
Avadel Pharmaceuticals plc was an Irish specialty pharmaceutical company focused on sleep disorder medicines marketed for hospital and primary care treatments. Headquartered in Dublin, Ireland, it had operations in St.